18:01:14 EDT Thu 28 Mar 2024
Enter Symbol
or Name
USA
CA



Goodness Growth Holdings Inc
Symbol GDNS
Shares Issued 86,721,030
Close 2022-11-10 C$ 0.55
Market Cap C$ 47,696,567
Recent Sedar Documents

Goodness Growth to release Q3 2022 results Nov. 14

2022-11-10 20:12 ET - News Release

Mr. Sam Gibbons reports

GOODNESS GROWTH HOLDINGS TO REPORT THIRD QUARTER RESULTS ON NOVEMBER 14, 2022

Goodness Growth Holdings Inc. will release financial results for its third quarter ended Sept. 30, 2022, on Monday, Nov. 14, 2022, after the market closes.

Goodness Growth management will host a conference call with the investment community the next day, Tuesday, November 15, 2022 at 8:30 a.m. ET (7:30 a.m. CT) to discuss its third-quarter results. Interested parties may attend the conference call by dialing 1-888-660-6217 (Toll-Free) (US and Canada) or 1-929-203-1990 (Toll) (International) and referencing conference ID number 2214400.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company's Investor Relations website.

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company's operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, Inc., and its science and intellectual property incubator, Resurgent Biosciences, Inc. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites, and distributes its products through its growing network of Green Goods(TM) and other retail locations and third-party dispensaries. Its team of more than 450 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in five markets and operates 18 dispensaries across the United States.

© 2024 Canjex Publishing Ltd. All rights reserved.